Breast (Apr 2021)

Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer

  • M. Ruiz-Borrego,
  • A. Chan,
  • G. Marx,
  • A. Brufsky,
  • M. Trudeau,
  • D. Egle,
  • L. McCulloch,
  • D. Tripathy,
  • C.H. Barcenas

Journal volume & issue
Vol. 56
pp. S18 – S19

Abstract

Read online

No abstracts available.